{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T08:38:01Z","timestamp":1782549481307,"version":"3.54.5"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["HL109002"],"award-info":[{"award-number":["HL109002"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["DK135076"],"award-info":[{"award-number":["DK135076"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73159-4","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T09:02:31Z","timestamp":1727686951000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["8-Aminoguanine and its actions in the metabolic syndrome"],"prefix":"10.1038","volume":"14","author":[{"given":"Edwin K.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delbert G.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaichuan","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Birder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stevan P.","family":"Tofovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"73159_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115076","volume":"201","author":"EK Jackson","year":"2022","unstructured":"Jackson, E. K., Menshikova, E. V., Ritov, V. B., Gillespie, D. G. & Mi, Z. Biochemical pathways of 8-aminoguanine production in Sprague-Dawley and Dahl salt-sensitive rats. Biochem. Pharmacol.201, 115076. https:\/\/doi.org\/10.1016\/j.bcp.2022.115076 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"73159_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1124\/jpet.116.237552","volume":"359","author":"EK Jackson","year":"2016","unstructured":"Jackson, E. K., Gillespie, D. G. & Mi, Z. 8-Aminoguanosine and 8-aminoguanine exert diuretic, natriuretic, glucosuric, and antihypertensive activity. J. Pharmacol. Exp. Ther.359, 420\u2013435. https:\/\/doi.org\/10.1124\/jpet.116.237552 (2016).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"73159_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1124\/jpet.117.243758","volume":"363","author":"EK Jackson","year":"2017","unstructured":"Jackson, E. K. & Mi, Z. 8-Aminoguanosine exerts diuretic, natriuretic, and glucosuric activity via conversion to 8-aminoguanine, yet has direct antikaliuretic effects. J. Pharmacol. Exp. Ther.363, 358\u2013366. https:\/\/doi.org\/10.1124\/jpet.117.243758 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"73159_CR4","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.118.010085","volume":"7","author":"EK Jackson","year":"2018","unstructured":"Jackson, E. K., Mi, Z., Kleyman, T. R. & Cheng, D. 8-Aminoguanine induces diuresis, natriuresis, and glucosuria by inhibiting purine nucleoside phosphorylase and reduces potassium excretion by inhibiting Rac1. J. Am. Heart Assoc.7, e010085. https:\/\/doi.org\/10.1161\/jaha.118.010085 (2018).","journal-title":"J. Am. Heart Assoc."},{"key":"73159_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1124\/jpet.122.001221","volume":"382","author":"EK Jackson","year":"2022","unstructured":"Jackson, E. K., Menshikova, E. V., Ritov, V. B., Mi, Z. & Birder, L. A. 8-Aminoinosine and 8-aminohypoxanthine inhibit purine nucleoside phosphorylase and exert diuretic and natriuretic activity. J. Pharmacol. Exp. Ther.382, 135\u2013148. https:\/\/doi.org\/10.1124\/jpet.122.001221 (2022).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"73159_CR6","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/hypertensionaha.122.20760","volume":"80","author":"EK Jackson","year":"2023","unstructured":"Jackson, E. K., Gillespie, D. G. & Mi, Z. 8-Aminoguanine and its actions on renal excretory function. Hypertension80, 981\u2013994. https:\/\/doi.org\/10.1161\/hypertensionaha.122.20760 (2023).","journal-title":"Hypertension"},{"key":"73159_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/s0163-7258(00)00097-8","volume":"88","author":"A Bzowska","year":"2000","unstructured":"Bzowska, A., Kulikowska, E. & Shugar, D. Purine nucleoside phosphorylases: Properties, functions, and clinical aspects. Pharmacol. Ther.88, 349\u2013425. https:\/\/doi.org\/10.1016\/s0163-7258(00)00097-8 (2000).","journal-title":"Pharmacol. Ther."},{"key":"73159_CR8","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.3390\/ijms25042251","volume":"25","author":"M Alemany","year":"2024","unstructured":"Alemany, M. The metabolic syndrome, a human disease. Int. J. Mol. Sci.25, 2251. https:\/\/doi.org\/10.3390\/ijms25042251 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"73159_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/j.ajkd.2009.01.255","volume":"53","author":"MP Alexander","year":"2009","unstructured":"Alexander, M. P. et al. Kidney pathological changes in metabolic syndrome: A cross-sectional study. Am. J. Kidney Dis.53, 751\u2013759. https:\/\/doi.org\/10.1053\/j.ajkd.2009.01.255 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"73159_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/487816","volume":"2015","author":"RG Peterson","year":"2015","unstructured":"Peterson, R. G. et al. Characterization of the ZDSD rat: A translational model for the study of metabolic syndrome and type 2 diabetes. J. Diabetes Res.2015, 487816. https:\/\/doi.org\/10.1155\/2015\/487816 (2015).","journal-title":"J. Diabetes Res."},{"key":"73159_CR11","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1113\/ep089947","volume":"107","author":"AN Wang","year":"2022","unstructured":"Wang, A. N., Carlos, J., Fraser, G. M. & McGuire, J. J. Zucker Diabetic-Sprague Dawley (ZDSD) rat: Type 2 diabetes translational research model. Exp. Physiol.107, 265\u2013282. https:\/\/doi.org\/10.1113\/ep089947 (2022).","journal-title":"Exp. Physiol."},{"key":"73159_CR12","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1161\/hypertensionaha.117.10765","volume":"72","author":"EK Jackson","year":"2018","unstructured":"Jackson, E. K., Gillespie, D. G., Mi, Z. & Cheng, D. Adenosine receptors influence hypertension in Dahl salt-sensitive rats: Dependence on receptor subtype, salt diet, and sex. Hypertension72, 511\u2013521. https:\/\/doi.org\/10.1161\/hypertensionaha.117.10765 (2018).","journal-title":"Hypertension"},{"key":"73159_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22349-z","volume":"12","author":"EK Jackson","year":"2022","unstructured":"Jackson, E. K. et al. Suppressed renoprotective purines in COVID-19 patients with acute kidney injury. Sci. Rep.12, 17353. https:\/\/doi.org\/10.1038\/s41598-022-22349-z (2022).","journal-title":"Sci. Rep."},{"key":"73159_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.120.020088","volume":"10","author":"EK Jackson","year":"2021","unstructured":"Jackson, E. K., Mi, Z., Gillespie, D. G., Cheng, D. & Tofovic, S. P. Long-term dipeptidyl peptidase 4 inhibition worsens hypertension and renal and cardiac abnormalities in obese spontaneously hypertensive heart failure rats. J. Am. Heart Assoc.10, e020088. https:\/\/doi.org\/10.1161\/jaha.120.020088 (2021).","journal-title":"J. Am. Heart Assoc."},{"key":"73159_CR15","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1681\/ASN.2015040397","volume":"27","author":"EK Jackson","year":"2016","unstructured":"Jackson, E. K. et al. Renal 2\u2032,3\u2032-cyclic nucleotide 3\u2032-phosphodiesterase is an important determinant of AKI severity after ischemia-reperfusion. J. Am. Soc. Nephrol.27, 2069\u20132081 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"73159_CR16","first-page":"4236","volume":"9","author":"RG Peterson","year":"2017","unstructured":"Peterson, R. G., Jackson, C. V. & Zimmerman, K. M. The ZDSD rat: A novel model of diabetic nephropathy. Am. J. Transl. Res.9, 4236\u20134249 (2017).","journal-title":"Am. J. Transl. Res."},{"key":"73159_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/714273","volume":"2014","author":"EP Davidson","year":"2014","unstructured":"Davidson, E. P. et al. Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley rat: A new animal model for type 2 diabetes. J. Diabetes Res.2014, 714273. https:\/\/doi.org\/10.1155\/2014\/714273 (2014).","journal-title":"J. Diabetes Res."},{"key":"73159_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2022.115319","volume":"206","author":"AN Wang","year":"2022","unstructured":"Wang, A. N., Carlos, J., Singh, K. K., Fraser, G. M. & McGuire, J. J. Endothelium dysfunction in hind limb arteries of male Zucker Diabetic-Sprague Dawley rats. Biochem. Pharmacol.206, 115319. https:\/\/doi.org\/10.1016\/j.bcp.2022.115319 (2022).","journal-title":"Biochem. Pharmacol."},{"key":"73159_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165688","volume":"1866","author":"L Han","year":"2020","unstructured":"Han, L. et al. Molecular changes in hepatic metabolism in ZDSD rats-A new polygenic rodent model of obesity, metabolic syndrome, and diabetes. Biochim. Biophys. Acta Mol. Basis Dis.1866, 165688. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165688 (2020).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"73159_CR20","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.3892\/mmr.2016.4982","volume":"13","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. In vivo treatment of rat arterial adventitia with interleukin-1\u03b2 induces intimal proliferation via the JAK2\/STAT3 signaling pathway. Mol. Med. Rep.13, 3451\u20133458. https:\/\/doi.org\/10.3892\/mmr.2016.4982 (2016).","journal-title":"Mol. Med. Rep."},{"key":"73159_CR21","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/s42003-022-04255-2","volume":"5","author":"Y Xue","year":"2022","unstructured":"Xue, Y. et al. Macrophages regulate vascular smooth muscle cell function during atherosclerosis progression through IL-1\u03b2\/STAT3 signaling. Commun. Biol.5, 1316. https:\/\/doi.org\/10.1038\/s42003-022-04255-2 (2022).","journal-title":"Commun. Biol."},{"key":"73159_CR22","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1084\/jem.160.2.618","volume":"160","author":"MP Bevilacqua","year":"1984","unstructured":"Bevilacqua, M. P., Pober, J. S., Majeau, G. R., Cotran, R. S. & Gimbrone, M. A. Jr. Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J. Exp. Med.160, 618\u2013623. https:\/\/doi.org\/10.1084\/jem.160.2.618 (1984).","journal-title":"J. Exp. Med."},{"key":"73159_CR23","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1172\/jci112200","volume":"76","author":"MP Bevilacqua","year":"1985","unstructured":"Bevilacqua, M. P., Pober, J. S., Wheeler, M. E., Cotran, R. S. & Gimbrone, M. A. Jr. Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J. Clin. Investig.76, 2003\u20132011. https:\/\/doi.org\/10.1172\/jci112200 (1985).","journal-title":"J. Clin. Investig."},{"key":"73159_CR24","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1161\/hypertensionaha.123.22620","volume":"81","author":"D Baumann","year":"2024","unstructured":"Baumann, D. et al. IL-1R mediated activation of renal sensory nerves in DOCA-salt hypertension. Hypertension81, 1811\u20131821. https:\/\/doi.org\/10.1161\/hypertensionaha.123.22620 (2024).","journal-title":"Hypertension"},{"key":"73159_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168639","author":"E Melton","year":"2021","unstructured":"Melton, E. & Qiu, H. Interleukin-1\u03b2 in multifactorial hypertension: Inflammation, vascular smooth muscle cell and extracellular matrix remodeling, and non-coding RNA regulation. Int. J. Mol. Sci.https:\/\/doi.org\/10.3390\/ijms22168639 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"73159_CR26","first-page":"736","volume":"297","author":"EK Jackson","year":"2001","unstructured":"Jackson, E. K. & Herzer, W. A. Regional vascular selectivity of angiotensin II. J. Pharmacol. Exp. Ther.297, 736\u2013745 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"73159_CR27","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1042\/cs20201406","volume":"135","author":"K Akita","year":"2021","unstructured":"Akita, K. et al. Blocking of interleukin-1 suppresses angiotensin II-induced renal injury. Clin. Sci. (Lond.)135, 2035\u20132048. https:\/\/doi.org\/10.1042\/cs20201406 (2021).","journal-title":"Clin. Sci. (Lond.)"},{"key":"73159_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.3109\/10409238.2012.694844","volume":"47","author":"JK Dowling","year":"2012","unstructured":"Dowling, J. K. & O\u2019Neill, L. A. Biochemical regulation of the inflammasome. Crit. Rev. Biochem. Mol. Biol.47, 424\u2013443. https:\/\/doi.org\/10.3109\/10409238.2012.694844 (2012).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"73159_CR29","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1126\/science.6795718","volume":"214","author":"IS Kazmers","year":"1981","unstructured":"Kazmers, I. S. et al. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: Selective toxicity for T lymphoblasts. Science214, 1137\u20131139 (1981).","journal-title":"Science"},{"key":"73159_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1749-6632.1985.tb27125.x","volume":"451","author":"RB Gilbertsen","year":"1985","unstructured":"Gilbertsen, R. B. & Dong, M. K. Effects of 8-aminoguanosine, an inhibitor of purine nucleoside phosphorylase, on plasma nucleosides in Wistar rats. Ann. N.Y. Acad. Sci.451, 313\u2013314 (1985).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"73159_CR31","first-page":"63","volume":"59","author":"WR Osborne","year":"1986","unstructured":"Osborne, W. R. & Barton, R. W. A rat model of purine nucleoside phosphorylase deficiency. Immunology59, 63\u201367 (1986).","journal-title":"Immunology"},{"key":"73159_CR32","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1021\/jm00060a010","volume":"36","author":"JW Chern","year":"1993","unstructured":"Chern, J. W. et al. Nucleosides. 5. Synthesis of guanine and formycin B derivatives as potential inhibitors of purine nucleoside phosphorylase. J. Med. Chem.36, 1024\u20131031. https:\/\/doi.org\/10.1021\/jm00060a010 (1993).","journal-title":"J. Med. Chem."},{"key":"73159_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1667\/rr3552.1","volume":"165","author":"SV Gudkov","year":"2006","unstructured":"Gudkov, S. V., Shtarkman, I. N., Smirnova, V. S., Chernikov, A. V. & Bruskov, V. I. Guanosine and inosine display antioxidant activity, protect DNA in vitro from oxidative damage induced by reactive oxygen species, and serve as radioprotectors in mice. Radiat. Res.165, 538\u2013545. https:\/\/doi.org\/10.1667\/rr3552.1 (2006).","journal-title":"Radiat. Res."},{"key":"73159_CR34","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/00000658-200204000-00016","volume":"235","author":"L Liaudet","year":"2002","unstructured":"Liaudet, L. et al. Inosine exerts a broad range of antiinflammatory effects in a murine model of acute lung injury. Ann. Surg.235, 568\u2013578. https:\/\/doi.org\/10.1097\/00000658-200204000-00016 (2002).","journal-title":"Ann. Surg."},{"key":"73159_CR35","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1164\/ajrccm.164.7.2101013","volume":"164","author":"L Liaudet","year":"2001","unstructured":"Liaudet, L. et al. Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am. J. Respir. Crit. Care Med.164, 1213\u20131220. https:\/\/doi.org\/10.1164\/ajrccm.164.7.2101013 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"73159_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ejcts.2006.04.003","volume":"30","author":"G Szab\u00f3","year":"2006","unstructured":"Szab\u00f3, G. et al. Effects of inosine on reperfusion injury after heart transplantation. Eur. J. Cardiothorac. Surg.30, 96\u2013102. https:\/\/doi.org\/10.1016\/j.ejcts.2006.04.003 (2006).","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"73159_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1006\/jsre.2001.6192","volume":"99","author":"A Wakai","year":"2001","unstructured":"Wakai, A. et al. Inosine attenuates tourniquet-induced skeletal muscle reperfusion injury. J. Surg. Res.99, 311\u2013315. https:\/\/doi.org\/10.1006\/jsre.2001.6192 (2001).","journal-title":"J. Surg. Res."},{"key":"73159_CR38","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bbrc.2016.11.119","volume":"482","author":"YJ Kim","year":"2017","unstructured":"Kim, Y. J. et al. Hypoxanthine causes endothelial dysfunction through oxidative stress-induced apoptosis. Biochem. Biophys. Res. Commun.482, 821\u2013827. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.119 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"73159_CR39","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glad1171","author":"LA Birder","year":"2023","unstructured":"Birder, L. A. et al. Hypoxanthine induces signs of bladder aging with voiding dysfunction and lower urinary tract remodeling. J. Gerontol. A Biol. Sci. Med. Sci.https:\/\/doi.org\/10.1093\/gerona\/glad1171 (2023).","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"73159_CR40","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1007\/s12035-016-9866-6","volume":"54","author":"H Biasibetti","year":"2017","unstructured":"Biasibetti, H., Pierozan, P., Rodrigues, A. F., Manfredini, V. & Wyse, A. T. S. Hypoxanthine intrastriatal administration alters neuroinflammatory profile and redox status in striatum of infant and young adult rats. Mol. Neurobiol.54, 2790\u20132800. https:\/\/doi.org\/10.1007\/s12035-016-9866-6 (2017).","journal-title":"Mol. Neurobiol."},{"key":"73159_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/jnc.12324","volume":"126","author":"T Dal-Cim","year":"2013","unstructured":"Dal-Cim, T. et al. Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions. J. Neurochem.126, 437\u2013450. https:\/\/doi.org\/10.1111\/jnc.12324 (2013).","journal-title":"J. Neurochem."},{"key":"73159_CR42","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11302-015-9475-2","volume":"11","author":"B Bellaver","year":"2015","unstructured":"Bellaver, B. et al. Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway. Purinergic Signal11, 571\u2013580. https:\/\/doi.org\/10.1007\/s11302-015-9475-2 (2015).","journal-title":"Purinergic Signal"},{"key":"73159_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101882","volume":"41","author":"M Bortolotti","year":"2021","unstructured":"Bortolotti, M., Polito, L., Battelli, M. G. & Bolognesi, A. Xanthine oxidoreductase: One enzyme for multiple physiological tasks. Redox Biol.41, 101882. https:\/\/doi.org\/10.1016\/j.redox.2021.101882 (2021).","journal-title":"Redox Biol."},{"key":"73159_CR44","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1016\/j.bmc.2010.07.054","volume":"18","author":"JR Fern\u00e1ndez","year":"2010","unstructured":"Fern\u00e1ndez, J. R., Sweet, E. S., Welsh, W. J. & Firestein, B. L. Identification of small molecule compounds with higher binding affinity to guanine deaminase (cypin) than guanine. Bioorg. Med. Chem.18, 6748\u20136755. https:\/\/doi.org\/10.1016\/j.bmc.2010.07.054 (2010).","journal-title":"Bioorg. Med. Chem."},{"key":"73159_CR45","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.115.002276","volume":"4","author":"ST Hardy","year":"2015","unstructured":"Hardy, S. T. et al. Reducing the blood pressure-related burden of cardiovascular disease: Impact of achievable improvements in blood pressure prevention and control. J. Am. Heart Assoc.4, e002276. https:\/\/doi.org\/10.1161\/jaha.115.002276 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"73159_CR46","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archinte.1995.00430070053006","volume":"155","author":"NR Cook","year":"1995","unstructured":"Cook, N. R., Cohen, J., Hebert, P. R., Taylor, J. O. & Hennekens, C. H. Implications of small reductions in diastolic blood pressure for primary prevention. Arch. Intern. Med.155, 701\u2013709 (1995).","journal-title":"Arch. Intern. Med."},{"key":"73159_CR47","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/01.HYP.0000120971.49659.6a","volume":"43","author":"T Mori","year":"2004","unstructured":"Mori, T. & Cowley, A. W. Jr. Role of pressure in angiotensin II-induced renal injury: Chronic servo-control of renal perfusion pressure in rats. Hypertension43, 752\u2013759. https:\/\/doi.org\/10.1161\/01.HYP.0000120971.49659.6a (2004).","journal-title":"Hypertension"},{"key":"73159_CR48","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med.377, 1119\u20131131. https:\/\/doi.org\/10.1056\/NEJMoa1707914 (2017).","journal-title":"N. Engl. J. Med."},{"key":"73159_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/fjc.0000000000000658","volume":"73","author":"S Toldo","year":"2019","unstructured":"Toldo, S. et al. The NLRP3 inflammasome inhibitor, OLT1177 (dapansutrile), reduces infarct size and preserves contractile function after ischemia reperfusion injury in the mouse. J. Cardiovasc. Pharmacol.73, 215\u2013222. https:\/\/doi.org\/10.1097\/fjc.0000000000000658 (2019).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"73159_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0114287","volume":"9","author":"II Shemesh","year":"2014","unstructured":"Shemesh, I. I., Rozen-Zvi, B., Kalechman, Y., Gafter, U. & Sredni, B. AS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: Regulation of the AKT downstream pathway. PLoS One9, e114287. https:\/\/doi.org\/10.1371\/journal.pone.0114287 (2014).","journal-title":"PLoS One"},{"key":"73159_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914928","author":"J Xing","year":"2023","unstructured":"Xing, J., Zhang, J. & Wang, J. The immune regulatory role of adenosine in the tumor microenvironment. Int. J. Mol. Sci.https:\/\/doi.org\/10.3390\/ijms241914928 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"73159_CR52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41586-022-05041-0","volume":"609","author":"B Niemann","year":"2022","unstructured":"Niemann, B. et al. Apoptotic brown adipocytes enhance energy expenditure via extracellular inosine. Nature609, 361\u2013368. https:\/\/doi.org\/10.1038\/s41586-022-05041-0 (2022).","journal-title":"Nature"},{"key":"73159_CR53","doi-asserted-by":"publisher","first-page":"F10","DOI":"10.1152\/ajprenal.2002.282.1.F10","volume":"282","author":"MD Okusa","year":"2002","unstructured":"Okusa, M. D. A2A adenosine receptor: A novel therapeutic target in renal disease. Am. J. Physiol. Renal Physiol.282, F10\u2013F18 (2002).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"73159_CR54","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/apha.12508","volume":"214","author":"IS Vincent","year":"2015","unstructured":"Vincent, I. S. & Okusa, M. D. Adenosine 2A receptors in acute kidney injury. Acta Physiol. (Oxf)214, 303\u2013310. https:\/\/doi.org\/10.1111\/apha.12508 (2015).","journal-title":"Acta Physiol. (Oxf)"},{"key":"73159_CR55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050137","volume":"5","author":"A Grenz","year":"2008","unstructured":"Grenz, A. et al. The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS Med.5, e137. https:\/\/doi.org\/10.1371\/journal.pmed.0050137 (2008).","journal-title":"PLoS Med."},{"key":"73159_CR56","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-540-89615-9_7","author":"JP Headrick","year":"2009","unstructured":"Headrick, J. P. & Lasley, R. D. Adenosine receptors and reperfusion injury of the heart. Handb. Exp. Pharmacol.https:\/\/doi.org\/10.1007\/978-3-540-89615-9_7 (2009).","journal-title":"Handb. Exp. Pharmacol."},{"key":"73159_CR57","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1152\/physiol.00032.2009","volume":"24","author":"MY Donath","year":"2009","unstructured":"Donath, M. Y., B\u00f6ni-Schnetzler, M., Ellingsgaard, H. & Ehses, J. A. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology (Bethesda)24, 325\u2013331. https:\/\/doi.org\/10.1152\/physiol.00032.2009 (2009).","journal-title":"Physiology (Bethesda)"},{"key":"73159_CR58","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/cjn.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic, R. Z., Rooney, M. T. & Tuttle, K. R. Diabetic kidney disease: Challenges, progress, and possibilities. Clin. J. Am. Soc. Nephrol.12, 2032\u20132045. https:\/\/doi.org\/10.2215\/cjn.11491116 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"73159_CR59","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cpcardiol.2017.05.001","volume":"43","author":"AA Oktay","year":"2018","unstructured":"Oktay, A. A. et al. Pathophysiology and prevention of heart disease in diabetes mellitus. Curr. Probl. Cardiol.43, 68\u2013110. https:\/\/doi.org\/10.1016\/j.cpcardiol.2017.05.001 (2018).","journal-title":"Curr. Probl. Cardiol."},{"key":"73159_CR60","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1681\/asn.2022010098","volume":"33","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Systematic review and meta-analysis of plasma and urine biomarkers for CKD outcomes. J. Am. Soc. Nephrol.33, 1657\u20131672. https:\/\/doi.org\/10.1681\/asn.2022010098 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"73159_CR61","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3389\/fimmu.2020.01257","volume":"11","author":"E Grunebaum","year":"2020","unstructured":"Grunebaum, E., Campbell, N., Leon-Ponte, M., Xu, X. & Chapdelaine, H. Partial purine nucleoside phosphorylase deficiency helps determine minimal activity required for immune and neurological development. Front. Immunol.11, 1257. https:\/\/doi.org\/10.3389\/fimmu.2020.01257 (2020).","journal-title":"Front. Immunol."},{"key":"73159_CR62","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/B978-012088451-3.50026-0","volume-title":"The Immune Response","author":"TW Mak","year":"2006","unstructured":"Mak, T. W. & Saunders, M. E. In The Immune Response (eds Mak, T. W. & Saunders, M. E.) 751\u2013783 (Academic Press, 2006)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73159-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73159-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73159-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T09:13:00Z","timestamp":1727687580000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73159-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73159"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73159-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Edwin K. Jackson and Stevan P. Tofovic are inventors (assignee, University of Pittsburgh) on issued patents related to 8-aminoguanine (US Patents 10,729,711 and 11,103,526 B2).  Edwin K. Jackson and Lori A. Birder are inventors (assignee, University of Pittsburgh) on pending patents related to 8-aminoguanine (US17\/434,894; US17\/799,546; PCT\/US2022\/042471; and EPO2179357.2).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22652"}}